Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Mais filtros










Intervalo de ano de publicação
11.
Gastroenterol Hepatol ; 30(5): 271-3, 2007 May.
Artigo em Espanhol | MEDLINE | ID: mdl-17493436

RESUMO

We describe the case of a 67 year old male with chronic hepatitis C on treatment with pegylated interferon and ribavirin who, after two and a half months of combined treatment, presented with a picture of acute mesenteric vein thrombosis that required urgent surgery. It re-occurred several days later and was his cause of death. In the thrombophilia study carried out immediately after surgery a decrease in protein C and S was considered as a cause of hypercoagulability. Protein C and S deficiency, natural anticoagulants synthesised in the liver, in patients without hepatic disease is a known cause of mesenteric thrombosis. Its decrease has also been described in the context of chronic hepatic diseases, including C virus chronic hepatitis, although it is not known for sure if this hypercoagulability state is a primary or secondary manifestation. Chronic hepatitis C and treatment with interferon has often been associated with a procoagulant state, and on many occasions due to different factors and mechanisms.


Assuntos
Antivirais/efeitos adversos , Hepatite C Crônica/complicações , Interferon-alfa/efeitos adversos , Oclusão Vascular Mesentérica/etiologia , Polietilenoglicóis/efeitos adversos , Deficiência de Proteína C/etiologia , Deficiência de Proteína S/etiologia , Ribavirina/uso terapêutico , Trombofilia/etiologia , Trombose Venosa/etiologia , Idoso , Antivirais/uso terapêutico , Quimioterapia Combinada , Evolução Fatal , Infecções por Bactérias Gram-Negativas/etiologia , Hemoperitônio/etiologia , Hepatite C Crônica/sangue , Hepatite C Crônica/tratamento farmacológico , Humanos , Interferon-alfa/uso terapêutico , Masculino , Oclusão Vascular Mesentérica/cirurgia , Veias Mesentéricas , Pneumonia Bacteriana/etiologia , Polietilenoglicóis/uso terapêutico , Recidiva , Respiração Artificial/efeitos adversos , Stenotrophomonas maltophilia , Trombectomia , Trombose Venosa/cirurgia
12.
Gastroenterol. hepatol. (Ed. impr.) ; 30(5): 271-273, may. 2007.
Artigo em Es | IBECS | ID: ibc-057423

RESUMO

Describimos el caso de un varón de 67 años de edad, con una hepatitis C crónica en tratamiento con interferón pegilado y ribavirina, que presentó, tras 2,5 meses de terapia combinada, un cuadro de trombosis mesentérica aguda que requirió cirugía urgente; tuvo una recidiva días después, que fue la causa de su fallecimiento. En el estudio de trombofilia durante el postoperatorio inmediato se constató un descenso de las proteínas C y S como causa de hipercoagulabilidad. La deficiencia de proteínas C y S, anticoagulantes naturales sintetizados en el hígado, en pacientes sin hepatopatía es una causa conocida de trombosis mesentérica. También se ha descrito su disminución en el contexto de hepatopatías crónicas, entre ellas la hepatitis crónica por el virus C, aunque no se conoce con certeza si este estado de hipercoagulabilidad es un fenómeno primario o secundario. La hepatitis C crónica y el tratamiento con interferón se han asociado con frecuencia a un estado procoagulante por distintos factores y mecanismos


We describe the case of a 67 year old male with chronic hepatitis C on treatment with pegylated interferon and ribavirin who, after two and a half months of combined treatment, presented with a picture of acute mesenteric vein thrombosis that required urgent surgery. It re-occurred several days later and was his cause of death. In the thrombophilia study carried out immediately after surgery a decrease in protein C and S was considered as a cause of hypercoagulability. Protein C and S deficiency, natural anticoagulants synthesised in the liver, in patients without hepatic disease is a known cause of mesenteric thrombosis. Its decrease has also been described in the context of chronic hepatic diseases, including C virus chronic hepatitis, although it is not known for sure if this hypercoagulability state is a primary or secondary manifestation. Chronic hepatitis C and treatment with interferon has often been associated with a procoagulant state, and on many occasions due to different factors and mechanisms


Assuntos
Masculino , Idoso , Humanos , Hepatite C Crônica/complicações , Trombose/complicações , Deficiência de Proteína S/complicações , Deficiência de Proteína C/complicações , Hepatite C Crônica/tratamento farmacológico , Ribavirina/efeitos adversos , Interferons/efeitos adversos , Artérias Mesentéricas/lesões
14.
Med Sci Monit ; 12(6): CS53-6, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16733488

RESUMO

BACKGROUND: Portal vein thrombosis in adults is usually related to cirrhosis. There are several possible therapies. including anticoagulation, transjugular intrahepatic portosystemic shunt, balloon dilatation, local and systemic fibrinolytics agents. Hypercoagulable states are also reported in association with this disease entity. Eosinophilia may activate platelets and promote thrombosis due to proteins contained in intracytoplasmic granules, such as eosinophil cationic protein and major basic protein. There is only one paper in the medical literature linking eosinophilia and portal vein thrombosis. CASE REPORT: We present here the case of a middle-age woman with idiopathic eosinophilia and acute portal vein thrombosis with massive venous thrombosis, involving the mesenteric, splenic, inferior cava, iliac and femoral veins, successfully treated with systemic streptokinase. CONCLUSIONS: Acute portal vein thrombosis with associated mesenteric and splenic vein thrombosis is a potentially lethal coagulation disorder that can be treated successfully with systemic streptokinase.


Assuntos
Síndrome de Budd-Chiari/diagnóstico por imagem , Síndrome de Budd-Chiari/tratamento farmacológico , Veia Porta/patologia , Estreptoquinase/uso terapêutico , Terapia Trombolítica , Síndrome de Budd-Chiari/etiologia , Eosinofilia/complicações , Feminino , Humanos , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...